These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22093814)

  • 1. Leflunomide for cytomegalovirus: bench to bedside.
    Chacko B; John GT
    Transpl Infect Dis; 2012 Apr; 14(2):111-20. PubMed ID: 22093814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide.
    Waldman WJ; Knight DA; Lurain NS; Miller DM; Sedmak DD; Williams JW; Chong AS
    Transplantation; 1999 Sep; 68(6):814-25. PubMed ID: 10515382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide.
    Waldman WJ; Knight DA; Blinder L; Shen J; Lurain NS; Miller DM; Sedmak DD; Williams JW; Chong AS
    Intervirology; 1999; 42(5-6):412-8. PubMed ID: 10702725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of refractory CMV-infection following hematopoietic stem cell transplantation with the combination of foscarnet and leflunomide.
    Ehlert K; Groll AH; Kuehn J; Vormoor J
    Klin Padiatr; 2006; 218(3):180-4. PubMed ID: 16688677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leflunomide as part of the treatment for multidrug-resistant cytomegalovirus disease after lung transplantation: case report and review of the literature.
    Verkaik NJ; Hoek RA; van Bergeijk H; van Hal PT; Schipper ME; Pas SD; Beersma MF; Boucher CA; Jedema I; Falkenburg F; Hoogsteden HC; van den Blink B; Murk JL
    Transpl Infect Dis; 2013 Dec; 15(6):E243-9. PubMed ID: 24298985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of leflunomide in the treatment of complex cytomegalovirus syndromes.
    Avery RK; Mossad SB; Poggio E; Lard M; Budev M; Bolwell B; Waldman WJ; Braun W; Mawhorter SD; Fatica R; Krishnamurthi V; Young JB; Shrestha R; Stephany B; Lurain N; Yen-Lieberman B
    Transplantation; 2010 Aug; 90(4):419-26. PubMed ID: 20683281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective evaluation of leflunomide therapy for cytomegalovirus disease in renal transplant recipients.
    John GT; Manivannan J; Chandy S; Peter S; Fleming DH; Chandy SJ; Balakrishnan N; Krishnamurthy K; Kirubakaran MG; Jacob CK
    Transplant Proc; 2005 Dec; 37(10):4303-5. PubMed ID: 16387103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection.
    Avery RK; Bolwell BJ; Yen-Lieberman B; Lurain N; Waldman WJ; Longworth DL; Taege AJ; Mossad SB; Kohn D; Long JR; Curtis J; Kalaycio M; Pohlman B; Williams JW
    Bone Marrow Transplant; 2004 Dec; 34(12):1071-5. PubMed ID: 15489872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leflunomide failure to control recurrent cytomegalovirus infection in the setting of renal failure after allogeneic stem cell transplantation.
    Battiwalla M; Paplham P; Almyroudis NG; McCarthy A; Abdelhalim A; Elefante A; Smith P; Becker J; McCarthy PL; Segal BH
    Transpl Infect Dis; 2007 Mar; 9(1):28-32. PubMed ID: 17313468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral resistance in cytomegalovirus: an emerging problem in organ transplant recipients.
    Limaye AP
    Semin Respir Infect; 2002 Dec; 17(4):265-73. PubMed ID: 12497543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of multidrug-resistant cytomegalovirus retinitis with systemically administered leflunomide.
    Levi ME; Mandava N; Chan LK; Weinberg A; Olson JL
    Transpl Infect Dis; 2006 Mar; 8(1):38-43. PubMed ID: 16623819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant and salvage therapy with leflunomide for recalcitrant cytomegalovirus infections in hematopoietic cell transplantation recipients: A case series.
    El Chaer F; Mori N; Shah D; Oliver N; Wang E; Jan A; Doan V; Tverdek F; Tayar J; Ariza-Heredia E; Chemaly RF
    Antiviral Res; 2016 Nov; 135():91-96. PubMed ID: 27594527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent antiviral and immunosuppressive activities of leflunomide in vivo.
    Chong AS; Zeng H; Knight DA; Shen J; Meister GT; Williams JW; Waldman WJ
    Am J Transplant; 2006 Jan; 6(1):69-75. PubMed ID: 16433758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leflunomide: a possible alternative for gangciclovir sensitive and resistant cytomegalovirus infections.
    Sudarsanam TD; Sahni RD; John GT
    Postgrad Med J; 2006 May; 82(967):313-4. PubMed ID: 16679469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir.
    Razonable RR; Rivero A; Rodriguez A; Wilson J; Daniels J; Jenkins G; Larson T; Hellinger WC; Spivey JR; Paya CV
    J Infect Dis; 2001 Dec; 184(11):1461-4. PubMed ID: 11709790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of leflunomide in a cytomegalovirus infection resistant: a report of a case].
    Gómez Valbuena I; Alioto D; Serrano Garrote O; Ferrari Piquero JM
    Farm Hosp; 2016 Jan; 40(1):52-4. PubMed ID: 26882834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral drugs for cytomegalovirus diseases.
    Biron KK
    Antiviral Res; 2006 Sep; 71(2-3):154-63. PubMed ID: 16765457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of high-dose ganciclovir for a resistant cytomegalovirus infection due to UL97 mutation.
    West P; Schmiedeskamp M; Neeley H; Oberholzer J; Benedetti E; Kaplan B
    Transpl Infect Dis; 2008 Apr; 10(2):129-32. PubMed ID: 17605740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.
    Reddy AJ; Zaas AK; Hanson KE; Palmer SM
    J Heart Lung Transplant; 2007 Dec; 26(12):1286-92. PubMed ID: 18096480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can leflunomide play a role in cytomegalovirus disease prophylaxis besides its antirheumatic effects?
    Lu CH; Tsai JH; Wu MZ; Yu CL; Hsieh SC
    Antivir Ther; 2015; 20(1):93-6. PubMed ID: 24831792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.